In contrast, increasing expression of Pyk2 promoted tumor growth and shortened survival time through Wnt/β-catenin signaling by Pyk2-mediated stabilization of β-catenin and activation of c-Myc and Cyclin D1, the direct downstream targets of β-catenin [76]. The gene discussed is PTK2B; the disease is neoplasm.